Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aldo Scarpa

Showing results (411-420 of 602) with videos related to

Pageof 61
Sort By:
Anticancer Research|September 12, 2013
HER2/neu gene determination in women screened for breast carcinoma: how screening programs reduce the skyrocketing cost of targeted therapyMatteo Brunelli, Erminia Manfrin, Emilio Bria, et al.
World Journal of Gastroenterology|May 24, 2017
Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumorsSalvatore Paiella, Harmony Impellizzeri, Elisabetta Zanolin, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 25, 2024
Tackling challenges in rare diseases: The ISGACA approach on non-pancreatic cancers in the periampullary regionBas A Uijterwijk, Daniël H Lemmers, Alma L Moekotte, et al.
Blood|March 29, 2007
Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)Lindsay M Morton, Jennifer J Turner, James R Cerhan, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 28, 2023
Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivityQuan Zheng, Jiajia Tang, Alexandra Aicher, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|August 21, 2023
Systematic review of challenging issues in pathology of intraductal papillary mucinous neoplasmsLaura D Wood, N Volkan Adsay, Olca Basturk, et al.
The British Journal of Surgery|June 1, 2023
Pathological staging in postneoadjuvant pancreatectomy for pancreatic cancer: implications for adjuvant therapyLaura Maggino, Giuseppe Malleo, Stefano Crippa, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2021
IL17A critically shapes the transcriptional program of fibroblasts in pancreatic cancer and switches on their protumorigenic functionsGianluca Mucciolo, Claudia Curcio, Cecilia Roux, et al.
Environmental Health : a Global Access Science Source|October 28, 2025
Occupational exposure to formaldehyde and risk of lymphoma subtypes: results of a multicentre Italian case-control studyPierluigi Cocco, Federico Meloni, Carlotta Trobbiani, et al.
Neuroendocrinology|June 7, 2017
Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity Results from a Single-Center Surgical SeriesSalvatore Paiella, Giovanni Marchegiani, Marco Miotto, et al.
Pageof 61

Showing results (411-420 of 602) with videos related to

Sort By:
Pageof 61
Anticancer Research|September 12, 2013
HER2/neu gene determination in women screened for breast carcinoma: how screening programs reduce the skyrocketing cost of targeted therapyMatteo Brunelli, Erminia Manfrin, Emilio Bria, et al.
World Journal of Gastroenterology|May 24, 2017
Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumorsSalvatore Paiella, Harmony Impellizzeri, Elisabetta Zanolin, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 25, 2024
Tackling challenges in rare diseases: The ISGACA approach on non-pancreatic cancers in the periampullary regionBas A Uijterwijk, Daniël H Lemmers, Alma L Moekotte, et al.
Blood|March 29, 2007
Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)Lindsay M Morton, Jennifer J Turner, James R Cerhan, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 28, 2023
Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivityQuan Zheng, Jiajia Tang, Alexandra Aicher, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|August 21, 2023
Systematic review of challenging issues in pathology of intraductal papillary mucinous neoplasmsLaura D Wood, N Volkan Adsay, Olca Basturk, et al.
The British Journal of Surgery|June 1, 2023
Pathological staging in postneoadjuvant pancreatectomy for pancreatic cancer: implications for adjuvant therapyLaura Maggino, Giuseppe Malleo, Stefano Crippa, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2021
IL17A critically shapes the transcriptional program of fibroblasts in pancreatic cancer and switches on their protumorigenic functionsGianluca Mucciolo, Claudia Curcio, Cecilia Roux, et al.
Environmental Health : a Global Access Science Source|October 28, 2025
Occupational exposure to formaldehyde and risk of lymphoma subtypes: results of a multicentre Italian case-control studyPierluigi Cocco, Federico Meloni, Carlotta Trobbiani, et al.
Neuroendocrinology|June 7, 2017
Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity Results from a Single-Center Surgical SeriesSalvatore Paiella, Giovanni Marchegiani, Marco Miotto, et al.
Pageof 61